PFG
GILD icon

PAX Financial Group’s Gilead Sciences GILD Stock Holding History

PAX Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Sell
1,794
-424
-19% -$55.9K 0.03% 190
2026
Q1 		$309K Sell
2,218
-554
-20% -$77.6K 0.05% 160
2025
Q4 		$340K Sell
2,772
-94
-3% -$11.4K 0.06% 167
2025
Q3 		$318K Sell
2,866
-276
-9% -$31.4K 0.06% 178
2025
Q2 		$348K Sell
3,142
-812
-21% -$86.4K 0.07% 176
2025
Q1 		$443K Sell
3,954
-1,189
-23% -$123K 0.08% 179
2024
Q4 		$475K Sell
5,143
-2,957
-37% -$266K 0.09% 171
2024
Q3 		$679K Sell
8,100
-392
-5% -$29.9K 0.12% 145
2024
Q2 		$583K Buy
8,492
+861
+11% +$57.5K 0.11% 154
2024
Q1 		$559K Sell
7,631
-176
-2% -$13.5K 0.11% 173
2023
Q4 		$576K Sell
7,807
-584
-7% -$45.4K 0.12% 165
2023
Q3 		$629K Sell
8,391
-2
-0% -$154 0.14% 128
2023
Q2 		$647K Sell
8,393
-716
-8% -$57.1K 0.15% 127
2023
Q1 		$756K Buy
9,109
+28
+0.3% +$2.32K 0.18% 88
2022
Q4 		$780K Sell
9,081
-3,325
-27% -$263K 0.2% 82
2022
Q3 		$765K Buy
12,406
+85
+0.7% +$5.36K 0.2% 84
2022
Q2 		$762K Buy
12,321
+579
+5% +$35.8K 0.19% 79
2022
Q1 		$698K Buy
11,742
+2,039
+21% +$130K 0.16% 115
2021
Q4 		$705K Buy
9,703
+13
+0.1% +$895 0.16% 119
2021
Q3 		$677K Buy
9,690
+120
+1% +$8.43K 0.17% 112
2021
Q2 		$659K Buy
9,570
+491
+5% +$32.8K 0.17% 102
2021
Q1 		$587K Buy
9,079
+541
+6% +$34.9K 0.17% 98
2020
Q4 		$497K Buy
8,538
+1,526
+22% +$92.1K 0.16% 94
2020
Q3 		$443K Buy
7,012
+1,672
+31% +$116K 0.16% 94
2020
Q2 		$411K Buy
5,340
+333
+7% +$25.5K 0.16% 87
2020
Q1 		$399K Buy
5,007
+351
+8% +$24.3K 0.17% 74
2019
Q4 		$312K Buy
+4,656
New +$303K 0.13% 88

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAX Financial Group's GILD Position: Q2 2026 in Review

PAX Financial Group reduced its Gilead Sciences (GILD) stake by 19% in Q2 2026, selling an estimated $55.9K and leaving 1,794 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #190.

PAX Financial Group first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $780K in Q4 2022. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PAX Financial Group held 1,794 shares of Gilead Sciences worth $227K as of Q2 2026.
  • PAX Financial Group sold 424 Gilead Sciences shares in Q2 2026, an estimated $55.9K.
  • Gilead Sciences made up 0.03% of PAX Financial Group's portfolio in Q2 2026, its #190 holding.
  • PAX Financial Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • PAX Financial Group's Gilead Sciences position peaked at $780K in Q4 2022.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PAX Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.